// App-Quantinova.ai

OP0075 (2022) : FIBROBLAST/MACROPHAGE CROSSTALK VIA LACTATE: NEW THERAPEUTIC TARGET IN RHEUMATOID ARTHRITIS

Researchers

Presenter

  • V. Pucino

Principal Investigators

  • M. Nefla

  • V. Gauthier

  • S. A. Clayton

  • A. Filer

  • A. R. Clark

  • K. Raza

  • C. D. Buckley

Medical Centers

  • University of Birmingham, Inflammation and Ageing, Birmingham, United Kingdom

  • Oxford University, Kennedy Institute of Rheumatology, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Musculoskeletal

Disease

  • Rheumatoid arthritis

  • Osteoarthritis

Biomarkers

  • Monocarboxylate transporter 4

  • Interleukin 6

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • Roche Holding AG

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved